Showing 2,041 - 2,060 results of 2,756 for search 'materials dysfunction', query time: 0.11s Refine Results
  1. 2041

    Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes by Yu. I. Grinshtein, V. V. Shabalin, R. R. Ruf, S. A. Shalnova, O. M. Drapkina

    Published 2022-06-01
    “…We assessed the prevalence of hypertension (HTN), coronary artery disease, myocardial infarction (MI), stroke and renal dysfunction in the whole sample and in groups with different risk depending on AIP. …”
    Get full text
    Article
  2. 2042

    Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure by Hanna Jassim Dohei, Maitham Ali Al-Rikabi

    Published 2025-03-01
    “…It can arise from various conditions that impact ventricular filling (diastolic dysfunction) or myocardial contractility (systolic dysfunction). …”
    Get full text
    Article
  3. 2043

    Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up by D. V. Bogdanov, I. I. Shaposhnik

    Published 2019-11-01
    “…Based  on the results  of a long-term  follow-up, to determine  the clinical variants  of  hypertrophic  non-obstructive cardiomyopathy  (HNOCM) and  develop criteria for the progression of the disease.Material and methods. The results of long-term follow-up were evaluated  for 97 patients  with HNOCM, men — 57 (58,8%), women — 40 (41,2%), average  age — 42,5±1,52  years  (M±σ). …”
    Get full text
    Article
  4. 2044

    Cutaneous involvement of light chain deposition disease: A case report by Saba Vafaei-Nodeh, Hamid Masoudi

    Published 2024-12-01
    “…A biopsy of the skin revealed amorphous eosinophilic material within the superficial dermis. Using special stains, immunohistochemistry, and direct immunofluorescence, the deposits were confirmed to be kappa light chains.…”
    Get full text
    Article
  5. 2045

    Serum cytokine levels in patients with acute alcohol heart pathology by V. V. Gorbunov, A. V. Govorin, S. A. Alekseev

    Published 2006-04-01
    “…To investigate cardiohemodynamic parameters and serum cytokine levels in patients with severe alcohol intoxication (AI). Material and methods. In total, 100 patients with severe AI were examined. …”
    Get full text
    Article
  6. 2046
  7. 2047

    ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by A. A. Garganeeva, S. M. Bagreeva

    Published 2012-08-01
    “…material and methods. The study included 82 patients with CHD and Functional Class II–III stable angina. …”
    Get full text
    Article
  8. 2048

    Congenital Heart Disease from Infancy to Adulthood: Pathology and Nosology by Gaetano Thiene, Marny Fedrigo

    Published 2025-04-01
    “…Congenital heart diseases (CHDs) are usually defined as structural anomalies of the heart and great arteries, present since birth, that are due to embryological maldevelopment, with overt or potential dysfunction. Nowadays, most of the patients with CHD in adulthood (age > 18 years) had been operated on with success in infancy or childhood and undergo periodical screening. …”
    Get full text
    Article
  9. 2049

    Mildronate effects on cognitive function in elderly patients with arterial hypertension by S. V. Nedogoda, M. E. Statsenko, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. N. Chumachok, O. L. Bykova

    Published 2012-10-01
    “…To assess the effects of the “interval” (3 months of treatment, followed by treatment-free 3 months) and “persistent” (52 weeks) therapy with Mildronate (500 mg/d) in elderly patients with arterial hypertension (AH) and cognitive dysfunction. Material and methods. In total, 1800 elderly patients with AH and mild to moderate cognitive dysfunction were randomised into 3 groups. …”
    Get full text
    Article
  10. 2050

    DIZZINESS OF ISCHEMIC GENESIS: DESCRIPTION OF VESTIBULAR DISORDERS AND POSSIBILITY OF THERAPY by N. S. Alekseeva

    Published 2015-12-01
    “…Therapy with Betaserc in daily dose of 48 mg was held during 2 months.Results. Dysfunction of both peripheral and central parts of vestibular analyzer was revealed in all patients. …”
    Get full text
    Article
  11. 2051

    Early markers of renal damage in type 2 diabetes: role of vitamin D-binding protein by V.M. Yerokhovych, O.V. Karpenko, Ye.I. Ilkiv, N.M. Kobyliak, I.A. Paliienko, I.V. Dumka, Yu.I. Komisarenko

    Published 2025-04-01
    “…Materials and methods. A total of 123 patients with type 2 diabetes participated in the study. …”
    Get full text
    Article
  12. 2052

    Pediatric Sjögren’s Syndrome: Focus on Ocular Involvement and Diagnostic Challenges by Emanuela Del Giudice, Maria Carmela Saturno, Maria Grazia Fiorino, Danilo Iannetta, Luca Spadea, Vanessa Martucci, Alessia Marcellino, Mariateresa Sanseviero, Angela Mauro, Sandra Cinzia Carlesimo, Nicola Nante, Giovanni Guarducci, Leopoldo Spadea, Riccardo Lubrano, Maria Pia Paroli

    Published 2025-06-01
    “…Slit-lamp examination revealed inhomogeneous tear films in all patients and blepharitis in 66.7%, consistent with Meibomian gland dysfunction. Systemic features included arthralgia, Raynaud’s phenomenon, fatigue, and frequent seropositivity for ANA and anti-SSA/Ro antibodies. …”
    Get full text
    Article
  13. 2053

    Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality by Alexandru Gratian Naum, Irina Jari, Liliana Moisii, Andra Mara Ursu, Paloma Moisii

    Published 2024-09-01
    “…A second objective of the research was to investigate the relationship between imaging by PAOI and these biomarkers in different etiologies of PE. <i>Materials and Methods</i>: This study comprised 109 patients with PE, hospitalized and treated between February 2021 and August 2022. …”
    Get full text
    Article
  14. 2054

    Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide by Larissa Dăniluc, Adina Braha, Oana Elena Sandu, Carina Bogdan, Loredana Suhov, Lina Haj Ali, Alexandra-Iulia Lazăr-Höcher, Alexandra Sima, Adrian Apostol, Mihaela Viviana Ivan

    Published 2025-03-01
    “…<i>Conclusions:</i> These findings show that improved subclinical left ventricular systolic dysfunction is associated with improved glycemic control, visceral adiposity, and reduced insulin resistance, respectively, with improved lipid profiling.…”
    Get full text
    Article
  15. 2055

    Increasing prevalence of thyroid autoimmunity in childhood type 1 diabetes in the pre-COVID but not during the COVID era by Vivien Herczeg, Eszter Muzslay, Diána Czipó, Lili Terkovics, Johanna Takács, Réka Garai, Réka Garai, Fanni Kovács, Andrea Luczay, Anna Körner, Péter Tóth-Heyn

    Published 2025-01-01
    “…Children with AIT had a significantly elevated risk of thyroid dysfunction compared to those with only thyroid autoantibody positivity (p&lt;0.001).ConclusionOur results show a rise in the prevalence of thyroid autoimmunity among T1D children over the past decade, but our data do not support the assumed role of SARS-CoV-2 in the development of the disease.…”
    Get full text
    Article
  16. 2056

    Characteristics and Features of the Circulatory System Status in Patients with Liver Cirrhosis as a Disease of Multiple Organ Lesions: Pathogenesis; Diagnostics; Principles of thei... by Farmaha M., Abrahamovych M., Ferko M.

    Published 2017-09-01
    “…To analyze the studies on frequency, pathogenesis, clinics, diagnostics and treatment of polymorbid syntropic extrahepatic lesions of the cardiovascular system in patients with liver cirrhosis published until now. Materials and methods. We have worked on clinical research data for previous years and have analyzed a case of the disease of a particular patient who was under our observation. …”
    Get full text
    Article
  17. 2057

    ORTHOPEDIC RESTORATION OF PARTIAL TOOTH LOSS AND WAYS OF ITS IMPROVEMENT by I.R. Stupnytskyi, R.M. Stupnytskyi

    Published 2020-12-01
    “…At the same time, changes in the neuromuscular system, dysfunction of the temporomandibular joints (TMJ), aesthetic, phonetic and functional disorders are often involved in clinical symptoms. …”
    Get full text
    Article
  18. 2058

    Parameters of leukopoiesis and thrombocytopenia in early urosepsis as potential predictors of a lethal outcome in hospitalized patients by S. V. Fedosenko, Yu. O. Rodionova, A. I. Ivanova, M. B. Arzhanik, O. L. Semenova, S. V. Nesterovich, E. A. Starovoitova, A. P. Zima, D. A. Vinokurova, E. М. Kamaltynova, V. V. Kalyuzhin

    Published 2024-10-01
    “…The baseline level of organ dysfunction graded by the SOFA (Sequential Organ Failure Assessment) score was significantly higher in deceased patients than in survivors (6 points vs. 3 points, respectively; p = 0.001). …”
    Get full text
    Article
  19. 2059

    Expression of Vascular Endothelial Growth Factor and Interleukin-6 in bile duct healing with autologous parietal peritoneum: a non-inferiority experimental study in rabbits by Anung Noto Nugroho, Soetrisno Soetrisno, Ambar Mudigdo, Kristanto Yuli Yarso, Dono Indarto, Akmal Zhahir Wahyudi

    Published 2025-06-01
    “…Although traditional repair techniques such as primary suturing and Roux-en-Y hepaticojejunostomy are widely used, they carry risks of anastomotic complications and bile duct dysfunction. Autologous peritoneum has emerged as a potential alternative graft material due to its biocompatibility and regenerative properties. …”
    Get full text
    Article
  20. 2060

    The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2025-06-01
    “…Personalised prescribing to reduce the risk of hepatotoxicity requires studying the role of pharmacotherapy in the development of liver dysfunction in COVID-19 patients.AIM. This study aimed to identify the presence and strength of the relationship between an increase in alanine transaminase (ALT) levels and the use of potentially hepatotoxic medicinal products in hospitalised patients with COVID-19 to provide practising clinicians with a case-specific approach for selecting medicinal products with a lower risk of hepatotoxicity.MATERIALS AND METHODS. …”
    Get full text
    Article